Cancer and neoplasms
Multi-centre, single-arm, interventional trial of HIVEC® (hyperthermic intravesical mitomycin medac) for patients with BCG-unresponsive nonmuscle-invasive bladder cancer. (HIVEC-HEAT)
HIVEC is a Phase III,multi-centre,interventional,single-arm trial assessing the safety and effectiveness of Hyperthermic Intravesical Chemotherapy (HIVEC®) in BCG-unresponsive high-grade non-muscle-invasive bladder cancer (NMIBC) patients. Radical cystectomy has long been considered the standard of care for patients with BCG-unresponsive high-grade NMIBC which if untreated carries a high risk of progression. Many of these patients are elderly where morbidity and mortality associated with cystectomy are significant and cure is not their primary consideration. More recently,pembrolizumab has received FDA approval as an alternative ...
GO TO STUDY